- Dr. Monica Morrow of MSKCC was quoted in a New York Times article regarding a study she coauthored, which was recently published in The Journal of the American Medical Association, that revealed that removing cancerous lymph nodes proved unnecessary for many women with early breast cancer who had undergone chemotherapy and radiation.
- Charles Sawyers, a cancer expert and Howard Hughes Medical Institute Investigator at MSKCC, in a Wall Street Journal article responded to recent findings that have identified a combination of four genes that appear to play a critical role in determining whether prostate cancer in its early stages will go on to become an aggressive, lethal disease.
- MESOTHELIOMAhelp.net announced a collaboration between MSKCC and Agenus to test a cancer vaccine that is meant to activate and expand the “army” of T-cells, known to be responsible for killing tumor cells, and inhibit the agent that blocks T-cell signals from effectively killing the tumor.